Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.
Philip W. Wills
Now that Gene therapy's promise has been shown, the industry must focus on improving the manufacturing process and bring down costs.
Glad tidings of progress and confidence this (conference) season! But let’s not dismiss the emerging skills challenge as “humbug.”
The UK’s CGT Catapult has played a significant role in building the strong advanced therapy ecosystem in the UK, the largest outside the USA.
With many cell and gene therapies skipping phase III trials entirely, academics must get to grips with GMP early.
Cell and gene therapies have earned a high profile in recent years, but the field’s rate of growth has led to a gold rush on talent.
What if research hospitals could fully develop and process cell and gene therapies themselves?
Miguel Forte argues it’s time to fine tune the way we target solid tumors...
The gene therapy sector is booming, but can the industry address all the teething problems?
The cell and gene therapy industry has amazing statistics. But to reach the next level, the industry must address its talent gap.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.